Armata Pharmaceuticals, Inc. (ARMP)
5.95
-0.45
(-7.03%)
USD |
NYAM |
Jan 20, 12:13
Armata Pharmaceuticals EPS Diluted (Quarterly): -0.7363 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Agenus, Inc. | 1.944 |
| Integer Holdings Corp. | 1.114 |
| Liquidia Corp. | -0.0409 |
| AIM ImmunoTech, Inc. | -1.567 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.68M |
| Revenue (Quarterly) | 1.159M |
| Total Expenses (Quarterly) | 27.83M |
| Enterprise Value | 395.44M |
| Gross Profit Margin (Quarterly) | 68.08% |
| Profit Margin (Quarterly) | -2.30K% |
| Earnings Yield | -22.24% |
| Normalized Earnings Yield | -20.55 |